These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22903047)
21. Evaluation of the degradation of clonidine-loaded PLGA microspheres. Gaignaux A; Réeff J; De Vriese C; Goole J; Amighi K J Microencapsul; 2013; 30(7):681-91. PubMed ID: 23544878 [TBL] [Abstract][Full Text] [Related]
22. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
23. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Siepmann J; Elkharraz K; Siepmann F; Klose D Biomacromolecules; 2005; 6(4):2312-9. PubMed ID: 16004477 [TBL] [Abstract][Full Text] [Related]
24. Preparation and physicochemical characterization of T-OA PLGA microspheres. Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and Characterization of PLGA Shell Microcapsules Containing Aqueous Cores Prepared by Internal Phase Separation. Abulateefeh SR; Alkilany AM AAPS PharmSciTech; 2016 Aug; 17(4):891-7. PubMed ID: 26416284 [TBL] [Abstract][Full Text] [Related]
26. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257 [TBL] [Abstract][Full Text] [Related]
27. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635 [TBL] [Abstract][Full Text] [Related]
28. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
29. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. Zidan AS; Sammour OA; Hammad MA; Megrab NA; Hussain MD; Khan MA; Habib MJ AAPS PharmSciTech; 2006 Jul; 7(3):61. PubMed ID: 17025242 [TBL] [Abstract][Full Text] [Related]
30. Doxycycline delivery from PLGA microspheres prepared by a modified solvent removal method. Patel RS; Cho DY; Tian C; Chang A; Estrellas KM; Lavin D; Furtado S; Mathiowitz E J Microencapsul; 2012; 29(4):344-52. PubMed ID: 22263669 [TBL] [Abstract][Full Text] [Related]
31. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
32. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
33. Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. Martínez-Sancho C; Herrero-Vanrell R; Negro S J Control Release; 2004 Sep; 99(1):41-52. PubMed ID: 15342179 [TBL] [Abstract][Full Text] [Related]
34. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method. He J; Zhou Z; Fan Y; Zhou X; Du H J Microencapsul; 2011; 28(8):763-70. PubMed ID: 22034953 [TBL] [Abstract][Full Text] [Related]
35. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Ramazani F; Chen W; Van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ Int J Pharm; 2015 Mar; 482(1-2):123-30. PubMed ID: 25636301 [TBL] [Abstract][Full Text] [Related]
36. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857 [TBL] [Abstract][Full Text] [Related]
37. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres. Xu Q; Czernuszka JT J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617 [TBL] [Abstract][Full Text] [Related]
38. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Krishnamachari Y; Madan P; Lin S Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982 [TBL] [Abstract][Full Text] [Related]
39. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166 [TBL] [Abstract][Full Text] [Related]
40. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres. Gajendiran M; Divakar S; Raaman N; Balasubramanian S Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]